Skip to main content
Side panel
About
About Open Classroom
EUPATI Fellows
Our Impact
Learning Pathways
FAQ
Open Classroom
Learning Catalogue
Patient Expert Training Programme
Resources
Glossary
EUPATI Toolbox
Accessibility Resources
EUPATI website
More
You are currently using guest access
Log in
About
Collapse
Expand
About Open Classroom
EUPATI Fellows
Our Impact
Learning Pathways
FAQ
Open Classroom
Collapse
Expand
Learning Catalogue
Patient Expert Training Programme
Resources
Collapse
Expand
Glossary
EUPATI Toolbox
Accessibility Resources
EUPATI website
Home
Role of Patients and Patient Organisations in Medicines R&D
Patient advocacy in practice
Patient advocacy in practice
Return to course
Open course index
Completion requirements
View
Patient advocacy in practice
The following are some resources on patient advocacy practices with their hyperlink:
Advocacy versus Activism: What is the difference?
AIDS history
The Impatient Patient - Discussion of patient involvement in novel forms of knowledge production
AZT molecule
Jump to...
Jump to...
Code of practice on relationships between the pharmaceutical industry and patient organisations
Code of Practice between Patients’ Organisations and the Healthcare Industry
European Community Advisory Board (ECAB) Protocol
Challenging Environment
Partnering as a key success factor in pharmaceutical R&D
No 'one size fits all' solution
Licensing
Crowd Sourcing
Individual projects
Pre-competitive consortia
R&D Collaborations and Strategic Alliances
Alliance Management
Organisational Setup
Assessment
Code of practice on relationships between the pharmaceutical industry and patient organisations ►